Kiora Pharmaceuticals (KPRX) Interest & Investment Income (2014 - 2026)

Kiora Pharmaceuticals (KPRX) has reported Interest & Investment Income for 13 consecutive years, with $146232.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Interest & Investment Income fell 35.08% year-over-year to $146232.0; the trailing twelve-month figure through Jun 2026 stood at $677702.0 (down 43.03% YoY), and the FY2025 full-year result was $894002.0, down 28.64% from the prior year.
• Interest & Investment Income advanced to $146232.0 in Q2 2026 per KPRX's latest filing, from $139338.0 in the prior quarter.
• Across five years, Interest & Investment Income topped out at $438860.0 in Q4 2024 and bottomed at $217.0 in Q1 2022.
• Historically, Interest & Investment Income has averaged $171626.6 across 5 years, with a median of $190310.0 in 2025.
• The sharpest annual moves came in 2023 and 2025: Interest & Investment Income surged 3544.87% in 2023, then slumped 56.64% in 2025.
• Over 5 years, Interest & Investment Income stood at $1237.0 in 2022, then jumped by 3580.27% to $45525.0 in 2023, then jumped by 864.0% to $438860.0 in 2024, then plunged by 56.64% to $190310.0 in 2025, then dropped by 23.16% to $146232.0 in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $146232.0, $139338.0, and $190310.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.